(2026). Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis. Clinical & Translational Immunology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Seropositivity Against Rubella Virus Envelope Protein 1, but Not 2, Is Associated with an Increased Risk of Multiple Sclerosis."
Clinical & Translational Immunology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Seropositivity Against Rubella Virus Envelope Protein 1, but Not 2, Is Associated with an Increased Risk of Multiple Sclerosis."
Clinical & Translational Immunology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.